Serious adverse events reported in case reports include ischemic priapism (documented post-2 mg subcutaneous administration), severe tachycardia, pupillary dilation, sweating, and muscle tremors
The American clinical-stage GLP-1 specialist is the maker of pemvidutide, which is being evaluated in phase 2 trials for obesity and nonalcoholic steatohepatitis (NASH)
ProRx and, reportedly, BPI Labs, stopped producing GLP-1s in April
This editorial breakdown, current as of April 2026, walks through what actually drives the monthly total and how to read it
The buildup of misfolded or damaged proteins, such as amyloid- in AD and -synuclein in PD, occurs due to the failure of these pathways, causing cellular stress, inflammation, and neurodegeneration
Amino acids as nutrients, in particular leucine, arginine, and glutamine, are the most effective activators of mTORC1